BDBM503537 N-[(7S)-4-fluorobicyclo[4.2.0]octa- 1,3,5-trien-7-yl]-N'-hydroxy-4-{2- [(3R)-3-hydroxypyrrolidin-1-yl]-2- oxoethoxy}-1,2,5-oxadiazole-3- carboximidamide::US11034661, Example 44

SMILES O\N=C(/N[C@H]1Cc2ccc(F)cc12)c1nonc1OCC(=O)N1CC[C@@H](O)C1

InChI Key InChIKey=SCXDCZPDDKTBAC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 503537   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM503537(N-[(7S)-4-fluorobicyclo[4.2.0]octa- 1,3,5-trien-7...)
Affinity DataIC50: 866nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 μM delta aminole...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2021
Entry Details
US Patent